Jagsonpal Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 67.37 | 75.92 | 77.49 |
| Operating Expense | 53.04 | 58.76 | 58.03 |
| Net Profit | 8.76 | 10.95 | 12.57 |
| Net Profit Margin | 13.00% | 14.42% | 16.22% |
| Earning Per Share | 1.25 | 1.67 | 1.88 |
| EBIDTA | 13.79 | 17.35 | 19.04 |
| Effective Tax Rate | 17.17% | 21.85% | 19.58% |
Particulars
Mar 2026
Revenue67.37
Operating Expense53.04
Net Profit8.76
Net Profit Margin13.00
Earning Per Share1.25
EBIDTA13.79
Effective Tax Rate17.17
